H. Mukae

Nocturnal difference in the ultra low frequency band of heart rate variability in patients stratified by Kampo medicine prescription.

J. Hayashi, N. Furusyo, M. Kainuma, 2014, Circulation journal : official journal of the Japanese Circulation Society.

A case of granulomatosis with polyangiitis preceded by subacute thyroiditis

J. Hayashi, N. Furusyo, M. Kainuma, 2014, Clinical case reports.

IL‐15 is a biomarker involved in the development of rapidly progressive interstitial lung disease complicated with polymyositis/dermatomyositis

K. Furukawa, H. Nakamura, H. Mukae, 2020, Journal of internal medicine.

The relation of postprandial plasma glucose and serum endostatin to the urinary albumin excretion of residents with prediabetes: results from the Kyushu and Okinawa Population Study (KOPS)

J. Hayashi, H. Ikezaki, N. Furusyo, 2016, International Urology and Nephrology.

Serum WFA+‐M2BP is a non‐invasive liver fibrosis marker that can predict the efficacy of direct‐acting anti‐viral‐based triple therapy for chronic hepatitis C

J. Hayashi, N. Furusyo, H. Mukae, 2016, Alimentary pharmacology & therapeutics.

Bioelectrical Impedance Analysis (BIA) of the association of the Japanese Kampo concept “Suidoku” (fluid disturbance) and the body composition of women

T. Shimazoe, N. Furusyo, T. Kubota, 2016, BMC Complementary and Alternative Medicine.

The utility of visceral fat level by bioelectrical impedance analysis in the screening of metabolic syndrome - the results of the Kyushu and Okinawa Population Study (KOPS).

J. Hayashi, N. Furusyo, H. Mukae, 2012, Journal of atherosclerosis and thrombosis.

Raloxifene hydrochloride is an adjuvant antiviral treatment of postmenopausal women with chronic hepatitis C: a randomized trial.

J. Hayashi, H. Ikezaki, N. Furusyo, 2012, Journal of hepatology.

Subclinical carotid atherosclerosis and triglycerides predict the incidence of chronic kidney disease in the Japanese general population: results from the Kyushu and Okinawa Population Study (KOPS).

J. Hayashi, H. Ikezaki, N. Furusyo, 2015, Atherosclerosis.

Impact of HCV kinetics on treatment outcome differs by the type of real-time HCV assay in NS3/4A protease inhibitor-based triple therapy.

J. Hayashi, T. Uchiumi, N. Furusyo, 2016, Antiviral research.